NEW YORK, Nov. 21 (GenomeWeb News) - Proteomics separations start-up ProteinForest announced today that it has closed a $19 million Series A financing.
The Watertown, Mass.-based company's technology consists of a suite of products centered around the ProteomeChip - developed by three Israeli physicists - which the company claims can separate and image all proteins in a biological sample in one hour or less, with high sensitivity, reproducibility, and accuracy. The company is currently led by CEO Russell Garlick, former vice president of R&D at PerkinElmer.
S.R. One, Boston Millennia Partners, IDG Venture, and Novo A/S led the Series A financing.